🇮🇳 Aptiom in India

Aptiom (ESLICARBAZEPINE ACETATE) regulatory status in India.

Marketing authorisation

CDSCO

  • Status: likely_approved

Aptiom in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in India

Frequently asked questions

Is Aptiom approved in India?

Yes. CDSCO has authorised it.

Who is the marketing authorisation holder for Aptiom in India?

Sumitomo Pharma Am is the originator. The local marketing authorisation holder may differ — check the official source linked above.